Trinidad and Tobago vs United States of America: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Trinidad and Tobago
96.0%
in 2025
United States of America
95.0%
in 2025
Trinidad and Tobago rank
26th
United States of America rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Trinidad and Tobago
- United States of America
How they compare
Trinidad and Tobago currently reports 96.0% against 95.0% in United States of America, a difference of 1.0%.
The two have swapped places 5 times across 26 shared years of data; in 2000 it was United States of America ahead.
Trinidad and Tobago ranks 26th and United States of America ranks 29th of 194 countries.
United States of America has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Trinidad and Tobago | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.8% | 86.2% | 14.4% | United States of America |
| 2010s | 85.6% | 92.3% | 6.7% | United States of America |
| 2020s | 91.0% | 95.0% | 4.0% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Trinidad and Tobago or United States of America?
- Trinidad and Tobago, at 96.0% against 95.0% in United States of America as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Trinidad and Tobago and United States of America?
- 1.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and United States of America?
- 26 years are reported by both, from 2000 to 2025.
- How do Trinidad and Tobago and United States of America rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Trinidad and Tobago ranks 26th and United States of America ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.